geoff cutmore in hong kong derisking your portfolio >> gd dprx, tadax. >> xlu if you want to redisk. >> stick wit >> gold. >> "mad money" starts right now. my mission is simple to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere, and i promise to help you find it. "mad money" starts now hey, i'm cramer. welcome to "mad money. welcome to cramerica other people want to make friends. i'm just trying to make you some money. my job is not just to entertain but to educate and teach you so call me at 1-800-743-cnbc or tweet me @jimcramer. nobody wants to profiteer off of a hurricane when you're dealing with a natural disaster that's killing people, the tragic loss of life

is what matters. but while this is no consolation for anyone who is caught in the hurricane's path, the truth is events like harvey, the kind that cause tremendous property damage, often he will top spur economic growth later on because of the need to rebuild when the water recedes and the danger passes, that might be worth thinking about however, the market in its entirety tends not to respond to natural disasters of any magnitude. hence the nature of today's averages with the dow dipping five points, s&p inching up and the nasdaq advancing 0.28% what the market does seem to respond to is news out of north korea. and we're now hearing reports that north korea fired a missile that's passed over japan the market is sending many stocks down in after hours trading. we're monitoring the situation for more information focusing again on hurricane harvey, i have no doubt there will be a massive rebuilding effort that will require insurance money and federal. in the end, it's not big enough

yet to impact the day-to-day action if you want to hear what the storm means for investors, i have some positives and negatives later in the show. but if you want to talk about the themes that dominated today's session before north korea, harvey is not one of them we got some specific data points that colored the action. the biggest word being that apple may be launching its new iphone as soon as september 12, much earlier than wall street expected that news propelled the stock of the world's largest company, it rallied $1.61, and sent many tech followers to wonder what is the entire feffect of the apple ecosystem. don't overthink the question of who wins the new iphone iteration. apple wins apple is just pennies away from a new high here, and this market, stocks tend to spurt

higher after rejoining the 52-week list just own apple, don't tried to trade it on wednesday, cnbc will be interviewing warren buffett. he regards apple as the creator of the greatest consumer product of all time, and he struggles to understand why the stock trades at such a discount to other consumer product plays i suspect he'll reiterate his opinion. and that might be worth a few points even without the new phone. now that we know the phone is coming sooner than we thought, i bet his word also fuel enthusiasm more than you would expect the odd thing about the news of the september 12 iphone launch is how undued the stocks of apple suppliers were micron gained more than 2%, and that makes sense because of the components it makes. similarly, land research, which manufactures the equipment

companies that micron needs to produce chips continues its halting advance after being clobbered post a great quarter i like the latter very much, though i think micron is cheap broadcom saw their stocks fall that could be a buying opportunity. let me spell out the possibilities for broadcom it makes the most intellectual property in the iphone last thursday night, they reported -- and while it beat projections, the company failed to raise its forecast. i've been thinking a lot about this i think that was by design management knows the rules for talking about apple as a client. it's like the fight club the first rule of anal is you don't talk about apple i believe that if if they had raised their forecast with what apple expects, it would have

been violating that first rule therefore, i think this quarter for broadcom, which has caused the stock to shed a dozen straight points was incorrect. the friday dumpers were back today despite the push forward that iphone talked about that the apple news came out to me, these sellers are making a mistake. the pullback in broadcom is a clarion call to buy it broadcom is an amazing company and the stock is just too cheape ramp - apple ramp is about to occur doesn't make sense tomorrow is the third day for broadcom the strangest thing about the apple news is it triggered a rally in f.a.n.g

there's no real news about f.a.n.g. i mean, facebook, let's see the news flow, nothing amazon, yes, it's endless. the stock has been going down because of its perception it's going to use whole foods as a loss leader. in truth, whole foods had the most profitability of any retailers measured by square footage. so there's ample room for amazon to cut price but amazon's stock, which churned up today, is say in the cross hairs of the shorts. let me give you a theory why it rallied. after every weather related situation that's made people home bound, there's been a big spurt in amazon sales. this time, with houston, it will be even bigger why? let me give you the pattern. many people stuck at home, okay, once the area returns to normal, the infrastructure, particularly the retail infrastructure, does not get back to normal so these stay-at-home folks use

amazon typically that causes a rush to amazon sales and more online shopping you can see this come to life with amazon stock, which reversed today so did the stocks of fedex and ups. there's nothing new at netflix to explain the advanced but these are frequent fellow travelers to apple alphabet has a stock that's struggled mightily of late for no apparent reasons. the other drivers of the stock market, gilead, one of several cancer therapy companies gilead spent $11.9 billion to acquire cutty. and i'm sure you're wondering how the stock could rally on a deal for paying for a company that's a money loser for years, gilead sat on cash gener

generated by its hepatitis c cure i any tthink the stock has more to run the fact is, there are far too many companies that need to find ways to come up with new drugs and cut costs. that's what happens when you merge with another pharmaceutical company i think the possibility that many of these will get a bid is fanciful but there's plenty of reasons why would company could merge with another, and i do have a cautionary tale about one particular biotech later in the show here's the bottom line while harvey dominates the headlines, takeovers and accelerated iphone launch explain more of today's gyrations. but we're monitoring the north korean situation always remember what matters to normal people isn't necessarily what matters to the stock market let's go to bob in massachusetts, bob >> caller: hey, jim, thanks for all you're doing

>> i'm doing my best thank you. thank you, bob >> caller: question for you. about six months ago, eric demarco, ceo of a company was on the show their product is unmanned jet propelled missiles in this second quarter conference call, they alluded that they will be getting some large orders between now and the first quarter of next year based upon their proprietary products. your thoughts? >> this news coming out of north korea, if we can find more about it, and the japanese have been saying that a missile flew over japan, would certainly produce a much higher price for the stock just tomorrow. now, the missile is in water but it doesn't matter. i think there will be another spurt in all of the defense stocks and they will figure

prominently in that. jonathan in california please, jonathan >> caller: cramer, thank you for everything that you've done. and a shoutout to my business associate, bruce my question is about this stock, is it worth holding? >> we go over the charts every single week and we agree that this one is trying to bottom out. i've got to tell you, i think the long-term for disney is very good i've not abandoned the situation, mr. iger, i believe in you william in florida, william. >> caller: hi, jim a long-time listener and i really respect your financial expertise. >> thank you >> caller: thank you for everything you do. but i think you've given a bum rap to this stock with a great balance sheet. would you consider having steven tanger, the ceo, come on your show >> absolutely. they were the ones that talked about some of the plans that

aren't as bullish. remember, this is a brave new world. the fact is, these stocks are going down, because there are concerns about rents, and concerns about growth. but i would certainly represent mr. tanger at any time harry in tennessee, please, harry. >> caller: yes, jim. over the years your comments made on the show have been very helpful. >> thank you >> caller: we're most appreciative today i would like your opinion of dardon restaurant >> the stock hascome down too much i think it's trying to settle in at that 3% yield it was a very big die, it's at 2.9% i believe that darden is ripe to buy. once again, watch thing north korean situation sending a lot of international stocks down but let's see what happens my thoughts and prayers go out to everyone impacted by this storm. for investors, well, they know that it's not hafbly moving

stocks, it's apple on "mad money" tonight, as the summer season comes to close, what could it mean for six flags? the stock has been on a roller coaster ride b we'll speak to the ceo and a critical u.s. industry is based in the middle of the texas flooding it's a company that's up 288% year-to-date but is it worth speculating on do not make a move before hearing my take. stick with cramer. >> don't miss a second of "mad money. follow @jimcramer at twitter have a question? tweet cramer at #madtweets send jim an e-mail to madmoney@cnbc.com or give us a call at 1-800-743-cnbc miss something he tmaon.cc.m.ado dmeynbco

and the wolf huffed and puffed... like you do sometimes, grandpa? well, when you have copd, it can be hard to breathe. it can be hard to get air out, which can make it hard to get air in. so i talked to my doctor. she said... symbicort could help you breathe better, starting within 5 minutes. symbicort doesn't replace a rescue inhaler

for sudden symptoms. symbicort helps provide significant improvement of your lung function. symbicort is for copd, including chronic bronchitis and emphysema. it should not be taken more than twice a day. symbicort contains formoterol. medicines like formoterol increase the risk of death from asthma problems. symbicort may increase your risk of lung infections, osteoporosis, and some eye problems. you should tell your doctor if you have a heart condition or high blood pressure before taking it. symbicort could mean a day with better breathing. watch out, piggies! (child giggles) symbicort. breathe better starting within 5 minutes. get symbicort free for up to one year. visit saveonsymbicort.com today to learn more.

♪ at a moment when people can't stop talking about the rise of the experiential economy, many millennials don't like to buy things as much as

they want to buy experiences that they can selfie how do we explain the weakness of the stock of six flags? the largest operator of regional theme parks in the world, with 20 in north america. but shares are down 13% year-to-date troubling. when the company reported at the end of july, six flagsearned 5 cents a share when they were looking for 70 cents revenue was weaker than expected, and per capita guest spending was down 2% ouch however, management was adamant that the weakness in the first half of the year was almost entirely due to the weather and they explained that the rest of the year would be a lot better could this stock be ready to turn around? let's look at that with the chairman of six flags entertainment to learn more how the company is doing welcome back to "mad money." >> great to be back. >> before we get started, your

company has long been associated with texas and i'm sure that there are some tough things tosay about how things are doing there so please, you've got the floor on that. >> jim, just as you would feel the same, our hearts go out to the people affected by the storm. and from our perspective, we have three parks in texas. san antonio is seeing a lot of rain so we closed the park there over the weekend. it has an affect on the texas parks. but as you started to state when you were describing the opening, we have 20 parks and we have a whole year in which to operate and we find that over a season, over a full year, we find that people tend to come, even if they don't come earlier on because of weather >> okay. now, we said returning ceo let's deal with this, what happened here. oppenheimier, in a report calling disappointing second quarter, they start out by saying in a disappointing release, one that provides an

explanation of the sudden retirement of john duffy, six flags reported their earnings. true or false? >> so the truth is, we did miss the analyst estimates. and we personally were disappointed where we finished but genre tired for personal reasons, and when you look at our performance, we had record revenue and record profitability in thesecond quarter even though it wasn't where we wanted it to be. so we know that we can do better and the reality is, i think there are many reasons why we are going to do better and i'm looking forward to talking about those. >> in a second but first, final clarification mr. duffy is 56. i'm 62 i'm not going anywhere there is a bit of what are you doing here >> i look at it as a huge positive >> i do, too but i want the stock higher. >> i'm one of the top five shareholders in the company.

and even last friday, i spent $3 million buying the company shares, because i believe that the stock price where it is today doesn't reflect the true value of the company a 5.1% yield, jim. that's the highest yield in the industry and so right now, it's an opportunity. if you go back and look at the last seven years, six of the seven years in this third quarter period, our stock has gone down. in fact, a year ago, we were at our 52-week low. so there's a trend that tends to develop. and this is a perfect time to buy. >> let's talk about the longer-term. you have water parks you obviously have this international business that's terrific and something else people need to know. there always has been a genuine catchup. i think people believe that. >> i think it's a really good point. what i would say is look, jim, there are many reasons why this is a good company. the most important is, long-term, we see huge opportunities. this is a great industry

in fact, it's a recurring revenue industry, and it's very stable even in a downturn. we're the most famous brand. if you think about regional theme parks, there's no better brand. >> people say wait a second, if this happens, that means the distribution may not go up >> and we've said very clearly, if you look at our goals, look at the $750 million that we have, we see the opportunity to not only increase our dividends in the high single, know double digit level, but also to buy back shares. >> i thought that was very interesting. one of the things people don't understand is the whole time i've been talking to you, i think anyone else that has been able to build a theme park from scratch, because the barriers may be the highest again, i need people to understand why that is, because people say why can't i put up a theme park >> people that have put up theme parks have failed. >> yes >> it's one of those things

where people speculate there's a theme park coming but there's nothing competitive. it costs $500 million to $700 million if you can get approvals to build theme parks >> meaning it's very difficult environmentally and insurance. you have the great safety record but if you start from scratch, you don't have any record. >> and we have 56 years in this industry proving that we can do this, and we have 20 parks we've just taken over two parks and opened them up >> and you talk about the next experience >> 40% increase in our season pass sales, jim. look, i'm going to say some things to you. first of all, we have so much opportunity in season passes less than a third of our guests, unique guests own a season pass. we're maybe in the fourth inning on our pricing opportunity we have this thing called the all-season dining pass, which is a tremendous growth opportunity. we have low penetration. we have international.

and then these water parks you add that up, it's opportunity just staring you right in the face with 5.1% yield. >> i've been out there saying listen, this is just the most consistent one look you in your eyes, listen to this, i totally agree. that's jim reed anderson, the chairman and returning ceo of six flags entertainment. you can't find good yielders >> i've got one more for you, this thursday, we're launching our biggest ever season pass flash sale up to 70% off, blow the roof off. you'll never get a better deal >> fair enough right there "mad money" is back after the break. thank you, jim great to see you

your brain is an amazing thing. but as you get older, it naturally begins to change, causing a lack of sharpness, or even trouble with recall. thankfully, the breakthrough in prevagen helps your brain and actually improves memory. the secret is an ingredient originally discovered... in jellyfish. in clinical trials, prevagen has been shown to improve short-term memory. prevagen. the name to remember.

♪ how do you get your head around an old testament style natural disaster like harvey

no two storms are alike, they're all terrible and the only thing that matters is people are dying. anything else is just much, much less important but i know many of you want to know if harvey has any impact on your investing so i have some ideas based on history. we can look back at past storms and see their impact on stocks but it's so mixed, it's hard to make any analogies that said, i've been tempted to put together a worst case scenario, especially for the insurance companies, using hurricane katrina, with a $100 billion price tag. just to make a judgment about the overall losses and what they'll mean for the group but before we get to that, let's figure out harvey's impact on the oil and gas industry to see if there's any money to be made off of it or lost, because houston might as well be the energy capital of america. first of all, in terms of oil and gas, the u.s. has become a radically different place versus where we were just a few years

ago. we now export about 5 million barrels a day, including 3 million barrels of refined product. let's say 30% of that product goes off line, reasonable assumption since so many refineries flooded that should jack up the price considerably around the country, even more than what's occurred valero is the single most dominant refiner and says it's not experiencing any material shutdowns. there should be a spike to valero's earnings. probably the worst hit will be the oil producers. off again today at $46 i think it could drop another 10%. permian producer also have nowhere to go. so much of the capacity is exported, which makes it even worse for them the pipelines, they'll suffer some outages, but they can get back on rather rapidly most of the pipe comes from the west to the gulf

that will simply be a function of people going to work, not destroying infrastructure, which brings us to the insurers. what kind of hit will they take from harvey? the initial pattern from katrina was instruction. people figured incorrectly the losses would hurt these companies badly. but in the end, they ended up rallying hard within three months of katrina. alstate rallied 10%, progressive up 20% these insurers are all buys after a day or two of selling. i suspect the federal flood program will bear the brunt of the losses here, but insurers will be able to raise rates of storm of this magnitude. back then, the old aig saw its stock rally 10% after the tragedy. as it was able to use katrina to raise rates.

excel group fell from 70 to 60, but back to 74 three months later. berkshire hathaway had a similar dip, then a rally. i like this choice most of all warren buffett will be bullish about his company's prospects. the two biggest brokers saw their stocks jump. i think it's because they were able to raise the premiums in tandem with the insurers cbre, the giant real estate broker, ahead of a 35% gain. that was the worst case number after katrina. could be here, too you think that the big box do it yourself retailers would cash in but lowe's or home depot neither showed a move. a better bet united reynolds, which saw its stock increase $3 today, but

only for the need for heavy equipment to clean things up for months i feel miserable telling you how to profit from this sad event. but history tells us what can happen, and that would apply here, which is why it's something we need to k and perhaps even act on. stick with cramer.

♪ when a little company with a red hot stock does a big equity offering, that tends to be a strong signal that you need to get more cautious. this is an educational beast, and we're going to use a particular stock to describe it. so when you're dealing with speculative, small capitalization companies, major secondary offerings are rarely a good sign, rarely. but let's consider the case of espr it's a development stage biotech focused on coming up with treatments for ldl cholesterol, the bad kind of cholesterol. they have an intriguing pipeline in the works but no products on the market yet, which means the stock is risky, even for a biotech.

this has been a real roller coaster. they became public at $14 a share. the stock bounced around in the teaches without getting much tracti traction but in the fall of 2014, the stock roared up to $112 by the spring of 2015 then the company did a large secondary offering shortly afterward, the stock got obliterated and by 2016, it was back down to the teens and where it stayed until recently but this year it's back up to $48.90 as of today if you were thinking this might make an attractive biotech speculation, it didn't have -- it wasn't making any money, maybe you should think twice there are a lot of things that make this a very risky story, maybe too risky for you. but what caught my attention is the fact that they took advantage of the recent strength to do another major secondary

offering, and given how the stock performed after the last one, i think we've got to start wondering if it's about to huz the momentum all over again, and that's very important when we're dealing with small cap companies of this ilk. let me give you some background. this is a good company it should be a very attractive story, speci the company spent years developing a novel drug that could reduce bad cholesterol with fewer side effects than statins. in fact, the guy who founded the company, dr. roger newton, is the inventor of lipitor, still the best selling drug in history. the company uses a different chemical pathway to cut back on your body's cholesterol production and so you can understand how many investors have gotten excited about this to be

high ldl cholesterol often leads to cardiovascular disease, the number one cause of death and disability in developed countries. we spend hundreds of millions dealing with the fallout o cardiovascular disease, and that's just in the u.s according to the cdc, something like 78 million american adults have elevated ldl cholesterol levels and the current crop of treatments does not necessarily work for everybody statins are effective, but there are a group of patients that can't take them because of side effects, like muscle pain, which is what i have elevated blood sugar and even kidney failure so this is a once daily pill that works by blocking the synthesis of bad cholesterol in your liver it's being evaluated in four different phase three trials that's all fabulous.

over this year, the stock came out of hibernation and mauled the short sellers. thanks largely to news that made people feel like its lead drug had more going than people thought. stock surged 29% of the good news of amgen's competing product. then the company announced its results of its lead drug in combination with the statin. kind of a cholesterol triple play kind of like the triple play the phillies pulled off this weekend. see that shortly after it closed that day, they filed to sell $150 million worth of stock two days later, the deal priced at $49 a share and the stock drifted down to $4 a8 and change where it remains today

no one likes it when the value of their existing shares is diluted by the creation of new stock. it matters less when you're not making any money i'm concerned, because i feel like deja vu it's like that great carl marx quote that history tends to repeat itself. the secondary that just happened has some eerie similarlies with the equity offering that crushed the stock in march of 2015 the company did two secondaries within six months of each other back then. the company sold $85 at $20 a share in october of 20 and the stock surged in march of 2014, they announced phase two data for its lead cholesterol drug in response, the stock folded 30% in a single session. then they say they're going to do a $150 million secondary offering to finish developing the drug deal priced at $100 a share in

mid march of 2015. the stock continued to rally but then it peaked at $115 in may and then got clobbered back to the teens given that it just did another $150 million secondary offering, i think it's worth asking what went wrong in the wake of the previous secondary, the last time the stock was red hot first, you have to remember the early stage biotech with no earnings and no sales, this stock trades on how people feel about its longer term prospects. that's why the early biotechs can be so volatile in the summer of 2015, the stock good slammed after the fda approved a different anti-cholesterol drug. then it got hit again when management suggested the lead drug might take longer to get approved sna that was a bad day for the stock. to make matters worse, last summer, they still hadn't gotten

an answer from the fda about what additional studies they would need to do to get their lead drug approved the stock lost 40% of its value on that news the investors worried that this drug might not ever get approved early stage biotech stories are inherently risky the last time they did a secondary offering, the stock lost 90% of its value before it bottomed i just think you need to be careful. and while the company has improved and it's further along and we love stage three, stocks like this, i've learned my lesson they're too risky for me to recommend on "mad money. let's go to carishna in michigan >> caller: hey, jim, how are you? >> very good how about you? >> caller: thank you doing great. a quick question, humira, what is the future --

>> this is precisely why you do not hear me talk about it in a positive way, even though the stock has been a horse and it's terrific i'm so concerned about the biosimilars, and this best se selling drug i've stayed away. i've been too cautious, but you're right to be concerned it hasn't played out yet is a reason to be concerned i just fear one day i come in and the stock is down big. dave in illinois, dave >> caller: hey, thoughts and prayers to all the good folks living along the texas and louisiana gulf coast today >> oh, boy, do we ever jees okay >> caller: jim, the health care sector has come alive today with news of gilgilead's purchase biotech was once considered your four horseman of the apocalypse.

they outperformed expectations for their bio similars, and other drugs. so jim, trading above their 50 day and 200 moving day afternoons, can biib return some of the luster of old or am i just -- >> no, dave, you've done a lot of homework and your homework is conclusive i think biogen is a buy. i think there are so many good things happening there, and this level is a very good level to get long once again, i congratulate you for doing a massive amount of homework before you call in. not that carishna didn't either, because his question is what's been keeping me from saying buy that company when a little company with a red hot stock does a secondary offering, i'm saying that's a sign of caution. early stage biotests are risky i've got to worry about the ones that don't work. tread with a little caution.

more "mad money" ahead the rain that's following harvey is still battering texas tonight, the economic impact of the storm. and then beavis systems is up 40%. you know we've liked it. can it continue to deliver healthy gains? and then tonight's edition of the lightning round. so stick with cramer i think that she's a very nice girl... you never got the brakes looked at? oh yeah. no. at cognizant, we're helping today's leading manufacturers make things that think and do automatically. imagine that, a world of new digital products and services all working together for you. can i borrow the car when it's back?

get ready, because we're helping leading companies see it- and see it through-with digital.

lightning round is sponsored by td ameritrade it is time it's time for the lightning round. [ indiscernible [ buzzer ] and then the lightning round is over are you ready, skedaddy. time for the lightning round michael in virginia, michael >> caller: boo-yah, jim. thanks for taking my call. my stock is tbr. >> which one is it kbr? okay, that's a construction company. could be an interesting play off of what's happening in houston but i am going to say hold off

because of the energy exposure logan in california, logan >> caller: boo-yah, jimbo. alaska air groups. >> i like alaska air i think they're inexpensive stocks brian in kansas. >> caller: jim, boo-yah. thanks for having me on the show >> of course >> caller: quick question about therapeutics got in there about $14 this month. your thoughts? >> the stock is up 100%. but it does have -- you know, look, they have the possibility of something for psychiatric disorders. so i'm going to tell you that the company is a good pick i know there's a lot of buzz about what this company is up to ed in california, ed >> caller: boo-yah, cramer greetings from cramerfornia. >> i like that

they're one-fifth of the country. >> caller: like so many other stocks, first solar. >> this company is coming back they're doing a lot of things right. >> buy buy buy >> they're doing a lot of work for our show anthem in arizona, anthem. >> caller: hey, jim, anthem here what is your outlook on deo group. >> this is incredible. it's been so strong. i am not going to give an opinion on this company until i can figure out why it was able to have such a big move in the last month let's go to andrew in massachusetts, andrew. >> caller: boo-yah, jim. how are you? >> all right, how are you? >> caller: doing well. long-time listener, first-time caller i'm curious to hear your thoughts on ticker symbol alsn >> alison transmissions, it is much more -- let's say related to trucks than cars. so therefore, i think it should

be going down. >> buy buy buy >> let's go to john in california, john >> caller: hello >> john, what's up >> caller: hey, jim, i was -- i've been holding ata for a while, and i was wondering what you think? >> what i've been telling people is that you cannot buy any more apache yet we have a position now, don't touch it it will come a level where it will be justified. we're not there yet. and that, ladies and gentlemen, is the conclusion of the lightning round. >> the lightning round is sponsored by td ameritrade so that i can take my trading platform wherever i go. you know that thinkorswim seamlessly syncs across all your devices, right? oh, so my custom studies will go with me? anywhere you want to go!

the market's hot! sync your platform on any device with thinkorswim. only at td ameritrade

♪ all right, what the heck just happened now to the stock of beavis systems? one of our favorites, maker of the cloud based systems. it helps make pharmaceutical sales more effective, captures clinical trial data a it's a story that i've liked for some time. but when veeva reported last thursday, the stock lost 15% of its value the next day and the market reaction wasn't just harsh, it was confusing. they delivered a higher than expected revenue, plus, management raised their

full-years sales and earnings forecast so why does the stock get obliterated? i think it has to do with the fact that the stock has run dramatically even of the decline, it's up 40% year-to-date and i think maybe investors were sto spoiled. so should we be concerned? let's take a look with the founder and ceo of veeva's systems. welcome back to "mad money." >> thanks, jim glad to be here. >> a tale of two cities here deutsche bank saying be careful, desseceleration to 28%, revenue fell below expectations. i have jpmorgan saying stronger than expected forecast new product, strong momentum, fantastic customer relations and three huge deals just signed please help me here.

can both of these be right >> well, jim, i guess variety is the spice of life, right so we want a little bit of that. but generally what we're focused on is the long-term. the basics, growing the top line of the company, the bottom line of the company that's something we've done every quarter since we've been public last quarter was a good quarter. 31% operating margin 26% subscription growth. so those are the things we're focused on i guess the big picture, we can develop here one of the few multibillion dollar profitable cloud companies over time. that just takes hard >> so peter, why do we have to hear about competitors metta data, we've had them on. but they came up is that something -- i've not heard competitors come up in your conference call before. >> we're getting relatively broad data we have a lot of products. in the clinical area, the

quality, the commercial area so you can bump into some competitors, and that's probably good for the market. so meta data would come up in the context of the clinical data so we have some early customers. and that's why meta data comes up but when you look at what veeva customers appreciate from us, we have multiple products on one cloud platform so it makes it easy. that's what they look to us for. >> now, i thought it was surprising i'm going through the conference call suddenly i hear two large chemical companies consumer products good company, industrial contract. i have long held that your fantastic software would help other silsilos how is this happening?

>> to make a really good product for a targeted area, we get some customers, get them live and happy and improve the products and do reference selling now we're doing that outside of experiences with our quality one product. it's for the quality processes you need those in, you know, cosmetics companies, chemical companies, food companies, industrial manufacturing you know, you have these quality processes, and we have an offering for them now, and we're just starting to get traction out there. so it's an exciting time >> i'm glad you mentioned that you get a company like iff or dupo dupont, dow chemical, they all have something in common, they're doing biologicals, they do things that we end up eating, or they do things that have claims that have to be protected and claiming that have to hold up under government scrutiny is that the kind of line extension we're thinking about >> we're talking about health

and human safety, absolutely but we're talking about quality as it refers to the brand reputation critically important not only that, and what's really driving the interest in veeva, because we have a true cloud software, these manufacturers have to involve their suppliers. the only way to do that is through a cloud based system and there just isn't one available we're going to serve thisund underserved market really bringing a cloud solution, and all of a sudden you've got a big market, that's what we're trying to do with quality one. there's a pent up demand there, and we're uncovering it. >>we went strong the moment they did that. if you can do the same thing, it becomes -- it's one company when you look at it in the health sciences it's another when you go as broad as you're thinking i like everything i heard today and i have a feeling that people

are not thinking big you have. thank you, peter great to talk to you, sir. >> thanks, jim this is one of those that's come down. there's people who don't believe. you either believe or don't, but i've done the homework, and to me it says there's a lot to the story. "mad money" is back after the break. closet fee. h your who is she, verizon? are those my heels? yeah! yeah, we're the same size...in shoes. with t-mobile taxes and fees are already included, so you get four lines of unlimited for just $40 bucks each. and now get zero down on the hottest smart phone brands like samsung galaxy. more reasons why t-mobile is america's best unlimited network.

all evening, obviously people are focused on this north korean missile that flew over japan and broke into pieces. and it is causing a lot of our stocks and the chinese stocks to go down. we want to know more about it before we make anything so determined as to say this is a reason to be able to lighten up on stocks. but you can see that people are taking that action in after hours trading. we'll certainly monitor the situation and have more later. i like to say there's always a bull market. i promise to try to find it for you here on "mad money." i'm jim cramer i'll see you tomorrow.

>> welcome to the shark tank, where entrepreneurs seeking an investment will face these sharks. if they hear a great idea, they'll invest their own money or fight each other for a deal. this is "shark tank." ♪ you always know who's at your front door. [ knock on door ] who's there? it's jamie, here to pitch. who? it's jamie.